COVID-19 and myocarditis: a brief review

Fatma Taher; Athar Eysa; Dalia Fahmy; Ahmed Shalaby; Ali Mahmoud; Moumen El-Melegy; Ahmed Abdel Khalek Abdel Razek; Ayman El-Baz

doi:10.31083/j.fbl2702073

COVID-19 and myocarditis: a brief review

Front Biosci (Landmark Ed). 2022 Feb 21;27(2):73. doi: 10.31083/j.fbl2702073.

Authors

Fatma Taher¹, Athar Eysa², Dalia Fahmy³, Ahmed Shalaby², Ali Mahmoud², Moumen El-Melegy⁴, Ahmed Abdel Khalek Abdel Razek³, Ayman El-Baz²

Affiliations

¹ The College of Technological Innovation, Zayed University, 19282 Dubai, UAE.
² Bioengineering Department, University of Louisville, Louisville, KY 40292, USA.
³ Department of Diagnostic Radiology, Mansoura faculty of medicine, 13551 Mansoura, Egypt.
⁴ Department of Electrical Engineering, Assiut University, 71515 Assiut, Egypt.

PMID: 35227016
DOI: 10.31083/j.fbl2702073

Abstract

Cardiovascular complications (especially myocarditis) related to COVID-19 viral infection are not well understood, nor do they possess a well recognized diagnostic protocol as most of our information regarding this issue was derived from case reports. In this article we extract data from all published case reports in the second half of 2020 to summarize the theories of pathogenesis and explore the value of each diagnostic test including clinical, lab, ECG, ECHO, cardiac MRI and endomyocardial biopsy. These tests provide information that explain the mechanism of development of myocarditis that further paves the way for better management.

Keywords: COVID-19; Myocarditis; SARS-CoV-2.

Publication types

Research Support, Non-U.S. Gov't
Review

MeSH terms

COVID-19*
Heart
Humans
Myocarditis* / diagnosis
Myocarditis* / etiology
Myocarditis* / pathology
SARS-CoV-2